These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 29624883)

  • 1. Diagnosis and management of ADA2 deficient polyarteritis nodosa.
    Human A; Pagnoux C
    Int J Rheum Dis; 2019 Jan; 22 Suppl 1():69-77. PubMed ID: 29624883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.
    Meyts I; Aksentijevich I
    J Clin Immunol; 2018 Jul; 38(5):569-578. PubMed ID: 29951947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.
    Özen S; Batu ED; Taşkıran EZ; Özkara HA; Ünal Ş; Güleray N; Erden A; Karadağ Ö; Gümrük F; Çetin M; Sönmez HE; Bilginer Y; Ayvaz DÇ; Tezcan I
    J Rheumatol; 2020 Jan; 47(1):117-125. PubMed ID: 31043544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders.
    Hashem H; Kelly SJ; Ganson NJ; Hershfield MS
    Curr Rheumatol Rep; 2017 Oct; 19(11):70. PubMed ID: 28983775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study.
    Caorsi R; Penco F; Grossi A; Insalaco A; Omenetti A; Alessio M; Conti G; Marchetti F; Picco P; Tommasini A; Martino S; Malattia C; Gallizzi R; Podda RA; Salis A; Falcini F; Schena F; Garbarino F; Morreale A; Pardeo M; Ventrici C; Passarelli C; Zhou Q; Severino M; Gandolfo C; Damonte G; Martini A; Ravelli A; Aksentijevich I; Ceccherini I; Gattorno M
    Ann Rheum Dis; 2017 Oct; 76(10):1648-1656. PubMed ID: 28522451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Novel Adenosine Deaminase 2 Gene Variants and Varied Clinical Phenotype in Pediatric Vasculitis.
    Gibson KM; Morishita KA; Dancey P; Moorehead P; Drögemöller B; Han X; Graham J; Hancock REW; Foell D; Benseler S; Luqmani R; Yeung RSM; Shenoi S; Bohm M; Rosenberg AM; Ross CJ; Cabral DA; Brown KL;
    Arthritis Rheumatol; 2019 Oct; 71(10):1747-1755. PubMed ID: 31008556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monogenic polyarteritis: the lesson of ADA2 deficiency.
    Caorsi R; Penco F; Schena F; Gattorno M
    Pediatr Rheumatol Online J; 2016 Sep; 14(1):51. PubMed ID: 27609179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of adenosine deaminase 2 (DADA2): Review.
    Sharma V; Deo P; Sharma A
    Best Pract Res Clin Rheumatol; 2023 Mar; 37(1):101844. PubMed ID: 37328410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment.
    Pinto B; Deo P; Sharma S; Syal A; Sharma A
    Clin Rheumatol; 2021 Oct; 40(10):3883-3896. PubMed ID: 33791889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 9.5-year-old boy with recurrent neurological manifestations and severe hypertension, treated initially for polyarteritis nodosa, was subsequently diagnosed with adenosine deaminase type 2 deficiency (DADA2) which responded to anti-TNF-α.
    Sahin S; Adrovic A; Barut K; Baran S; Tahir Turanli E; Canpolat N; Kizilkilic O; Ozkaya O; Kasapcopur O
    Paediatr Int Child Health; 2020 Feb; 40(1):65-68. PubMed ID: 30642227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-onset stroke and vasculopathy associated with mutations in ADA2.
    Zhou Q; Yang D; Ombrello AK; Zavialov AV; Toro C; Zavialov AV; Stone DL; Chae JJ; Rosenzweig SD; Bishop K; Barron KS; Kuehn HS; Hoffmann P; Negro A; Tsai WL; Cowen EW; Pei W; Milner JD; Silvin C; Heller T; Chin DT; Patronas NJ; Barber JS; Lee CC; Wood GM; Ling A; Kelly SJ; Kleiner DE; Mullikin JC; Ganson NJ; Kong HH; Hambleton S; Candotti F; Quezado MM; Calvo KR; Alao H; Barham BK; Jones A; Meschia JF; Worrall BB; Kasner SE; Rich SS; Goldbach-Mansky R; Abinun M; Chalom E; Gotte AC; Punaro M; Pascual V; Verbsky JW; Torgerson TR; Singer NG; Gershon TR; Ozen S; Karadag O; Fleisher TA; Remmers EF; Burgess SM; Moir SL; Gadina M; Sood R; Hershfield MS; Boehm M; Kastner DL; Aksentijevich I
    N Engl J Med; 2014 Mar; 370(10):911-20. PubMed ID: 24552284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of Adenosine Deaminase 2: Clinical Manifestations, Diagnosis, and Treatment.
    Grim A; Veiga KR; Saad N
    Rheum Dis Clin North Am; 2023 Nov; 49(4):773-787. PubMed ID: 37821195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy.
    Garg N; Kasapcopur O; Foster J; Barut K; Tekin A; Kızılkılıç O; Tekin M
    Eur J Pediatr; 2014 Jun; 173(6):827-30. PubMed ID: 24737293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two cases of ADA2 deficiency presenting as childhood polyarteritis nodosa: novel ADA2 variant, atypical CNS manifestations, and literature review.
    Ganhão S; Loureiro GB; Oliveira DR; Dos-Reis-Maia R; Aguiar F; Quental R; Moura C; Barreira JL; Rodrigues M; Brito I
    Clin Rheumatol; 2020 Dec; 39(12):3853-3860. PubMed ID: 32535845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatologic Features of ADA2 Deficiency in Cutaneous Polyarteritis Nodosa.
    Gonzalez Santiago TM; Zavialov A; Saarela J; Seppanen M; Reed AM; Abraham RS; Gibson LE
    JAMA Dermatol; 2015 Nov; 151(11):1230-4. PubMed ID: 26131734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case with febrile attacks and vasculopathy associated with ADA2 and MEFV pathogenic variants.
    Parlar K; Tahir Turanli E; Nuhoglu Kantarci E; Hacioglu A; Kirectepe Aydin A; Ayla AY; Voyvoda U; Ozdogan H; Ugurlu S
    Mod Rheumatol Case Rep; 2023 Dec; 8(1):121-124. PubMed ID: 37542433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence-Based Screening of Patients With Idiopathic Polyarteritis Nodosa, Granulomatosis With Polyangiitis, and Microscopic Polyangiitis for Deleterious Genetic Variants in ADA2.
    Schnappauf O; Sampaio Moura N; Aksentijevich I; Stoffels M; Ombrello AK; Hoffmann P; Barron K; Remmers EF; Hershfield M; Kelly SJ; ; Cuthbertson D; Carette S; Chung SA; Forbess L; Khalidi NA; Koening CL; Langford CA; McAlear CA; Monach PA; Moreland L; Pagnoux C; Seo P; Springer JM; Sreih AG; Warrington KJ; Ytterberg SR; Kastner DL; Grayson PC; Merkel PA;
    Arthritis Rheumatol; 2021 Mar; 73(3):512-519. PubMed ID: 33021335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histiocytoid Sweet Syndrome Presenting in Two Sisters With Deficiency of Deaminase Type 2.
    Hui Ong EL; Cooray S; Brogan P; Calonje E
    Am J Dermatopathol; 2023 Jan; 45(1):47-50. PubMed ID: 36484606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical phenotype of an old disease or typical phenotype of a new disease: deficiency of adenosine deaminase 2.
    Çakan M; Aktay-Ayaz N; Karadağ ŞG; Tahir-Turanlı E; Stafstrom K; Bainter W; Geha RS; Chou J
    Turk J Pediatr; 2019; 61(3):413-417. PubMed ID: 31916720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human adenosine deaminase 2 deficiency: A multi-faceted inborn error of immunity.
    Moens L; Hershfield M; Arts K; Aksentijevich I; Meyts I
    Immunol Rev; 2019 Jan; 287(1):62-72. PubMed ID: 30565235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.